17-18 June 2021 Virtual Conference
Manage increased granularity and frequency of portfolio optimization and scenario planning and stay ahead of the curve with the right prioritization and execution strategy
The 21st Edition ‘Strategic Project & Portfolio Management for Pharma’ is a marcus evans unique event taking place virtually on the 17th-18th of June 2021, bringing you closer to solutions in PPM at a time of great opportunity for change and great pressure on R&D PPM functions. By attending this event you will discuss practical approaches to aligning R&D and Portfolio Strategy and how to better manage disruptions, prioritization and reprioritization. You will engage in discussions with your peers on how to motivate your organisation to invest in long-term planning and capacity management, and how to create a non-bureaucratic, agile way of working in PPM. Join us for two exciting days of practical case studies and debate!
Attending this conference will enable you to:
• Align R&D and Portfolio Strategy and motivate your organisation to invest in long-term planning and capacity management
• Manage disruptions, prioritization and reprioritization
• Balance scientific (data-driven) vs. commercial considerations (aspirational) in portfolio prioritization
• Enhance project, program, and portfolio visibility to improve R&D Performance
• Create a non-bureaucratic, agile way of working in PPM: What does it take to adapt agile approaches in pharma?
• Accelerate investment in data sciences for better, more connected R&D insights
Learn from Key Practical Case Studies
• Bayer discuss implementation of value-focused thinking to improve the quality of early portfolio decisions
• Roche on contending with the pressure to get out projects faster and the impact on overall R&D
• Blueprint Medicines reflect on the importance of enhancing Project, Program, and Portfolio Visibility to Improve R&D Performance
• AstraZeneca explore how to create a non-bureaucratic, Agile Way of Working in PPM
• Novartis discuss disruptions, prioritization and reprioritization throughout the pandemic